Brief: Eledon Pharmaceuticals Provides Business And Pipeline Updates
09/01/2023 13:41
Jan 9 (Reuters) - Eledon Pharmaceuticals Inc ELDN.O :
* ELEDON PHARMACEUTICALS PROVIDES BUSINESS AND PIPELINE
UPDATES
* ELEDON PHARMACEUTICALS INC- SUFFICIENT FINANCIAL RESOURCES
TO
FUND OPERATING ACTIVITIES INTO 2024
* ELEDON PHARMACEUTICALS INC- COMPANY PLANS TO PRIORITIZE
AND
FOCUS RESOURCES ON ADVANCEMENT OF TEGOPRUBART IN KIDNEY
TRANSPLANTATION
Further company coverage: ELDN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eledon Pharmaceuticals
See all newsBrief: Eledon Presents Updated Long-Term Phase 2 Bestow Extension Study Results At The International Congress Of The Transplantation Society
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Eledon Pharmaceuticals Q2 net loss widens on warrant liability changes
Eledon Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial